AR002990A1 - Una nueva combinacion de un inhibidor de reabsorcion de 5-ht y un antagonista 5-ht(1a), su uso para la preparacion de medicamentos, una formulacion farmaceutica que la comprende, un procedimiento para la preparacion de dicha combinacion y equipo que contiene dicha combinacion. - Google Patents
Una nueva combinacion de un inhibidor de reabsorcion de 5-ht y un antagonista 5-ht(1a), su uso para la preparacion de medicamentos, una formulacion farmaceutica que la comprende, un procedimiento para la preparacion de dicha combinacion y equipo que contiene dicha combinacion.Info
- Publication number
- AR002990A1 AR002990A1 ARP960102323A AR10232396A AR002990A1 AR 002990 A1 AR002990 A1 AR 002990A1 AR P960102323 A ARP960102323 A AR P960102323A AR 10232396 A AR10232396 A AR 10232396A AR 002990 A1 AR002990 A1 AR 002990A1
- Authority
- AR
- Argentina
- Prior art keywords
- combination
- preparation
- antagonist
- pharmaceutical formulation
- medicines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención se refiere a una combinación de un primer componente (a) que es un inhibidor de reabsorción de 5-HT y un segundo componente (b) que es elantagonista selectivo 5-HT(1A) que tiene la fórmula general (I), en la cual R1 es n-propilo ocic lobutilo; R2 es isopropilo, butilo terciario, ciclobutilo,ciclopentilo o ciclohexilo; R3 es hidrógeno; R4 es hidrógeno o metilo; como enantiómero (R) en forma de una base libre o de sus sales farmacéuticamenteaceptables; la preparación delas mis mas; las formulaciones farmacéuticas que contienen dicha combinación, el uso y método de tratamiento de desórdenesafectivos tales como depresión, ansiedad y desorden compulsivo obsesivo (OCD) con dicha combinación, así como también unequipo que contiene dichacombinación, su uso para preparar medicamentos, una formulación farmacéutica que la comprende, un procedimiento para la preparación de dicha combinacióny un equipo que contiene dicha combinación.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501567A SE9501567D0 (sv) | 1995-04-27 | 1995-04-27 | A new combination |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002990A1 true AR002990A1 (es) | 1998-05-27 |
Family
ID=20398119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960102323A AR002990A1 (es) | 1995-04-27 | 1996-04-25 | Una nueva combinacion de un inhibidor de reabsorcion de 5-ht y un antagonista 5-ht(1a), su uso para la preparacion de medicamentos, una formulacion farmaceutica que la comprende, un procedimiento para la preparacion de dicha combinacion y equipo que contiene dicha combinacion. |
Country Status (30)
Country | Link |
---|---|
US (5) | US5962514A (es) |
EP (1) | EP0822813B1 (es) |
JP (1) | JPH11504037A (es) |
KR (1) | KR100419810B1 (es) |
CN (1) | CN1102386C (es) |
AR (1) | AR002990A1 (es) |
AT (1) | ATE216579T1 (es) |
BR (1) | BR9608252A (es) |
CA (1) | CA2218181A1 (es) |
CZ (1) | CZ335697A3 (es) |
DE (1) | DE69620878T2 (es) |
DK (1) | DK0822813T3 (es) |
EE (1) | EE03553B1 (es) |
ES (1) | ES2175089T3 (es) |
HK (1) | HK1002853A1 (es) |
HU (1) | HUP9801946A3 (es) |
IL (1) | IL117988A0 (es) |
IS (1) | IS1821B (es) |
NO (1) | NO317057B1 (es) |
NZ (1) | NZ306602A (es) |
PL (1) | PL183997B1 (es) |
PT (1) | PT822813E (es) |
RU (1) | RU2183955C2 (es) |
SE (1) | SE9501567D0 (es) |
SK (1) | SK282060B6 (es) |
TR (1) | TR199701254T1 (es) |
TW (1) | TW458777B (es) |
WO (1) | WO1996033710A1 (es) |
YU (1) | YU25696A (es) |
ZA (1) | ZA962982B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9501567D0 (sv) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
SE9703374D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | A new combination |
WO1999061014A2 (en) * | 1998-05-28 | 1999-12-02 | Sepracor Inc. | Compositions and methods employing r(-) fluoxetine and other active ingredients |
SE9803158D0 (sv) * | 1998-09-16 | 1998-09-16 | Astra Ab | A new composition |
SE9803155D0 (sv) * | 1998-09-16 | 1998-09-16 | Astra Ab | A new composition |
SE9803156D0 (sv) * | 1998-09-16 | 1998-09-16 | Astra Ab | A new composition |
SE9803157D0 (sv) * | 1998-09-16 | 1998-09-16 | Astra Ab | A new composition |
AR021155A1 (es) * | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
US6331233B1 (en) | 2000-02-02 | 2001-12-18 | Honeywell International Inc. | Tantalum sputtering target with fine grains and uniform texture and method of manufacture |
AU9543601A (en) | 2000-10-13 | 2002-04-22 | Neurosearch As | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
US20030166554A1 (en) * | 2001-01-16 | 2003-09-04 | Genset, S.A. | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
US20030185754A1 (en) * | 2001-01-16 | 2003-10-02 | Genset, S.A. | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
EP1385503A1 (en) * | 2001-05-01 | 2004-02-04 | H. Lundbeck A/S | The use of enantiomeric pure escitalopram |
US7034059B2 (en) | 2001-07-02 | 2006-04-25 | Sepracor Inc. | Methods of using norfluoxetine |
US6855735B2 (en) | 2002-03-20 | 2005-02-15 | Temple University Of The Commonwealth System Of Higher Education | Ketamine treatment of restless legs syndrome |
UA81423C2 (en) * | 2002-08-15 | 2008-01-10 | PRODUCT CONTAINING SRI AND AGONIST OF THE 5HT2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION | |
US20050032873A1 (en) * | 2003-07-30 | 2005-02-10 | Wyeth | 3-Amino chroman and 2-amino tetralin derivatives |
US7695601B2 (en) * | 2006-05-09 | 2010-04-13 | The United States Of America As Represented By The Secretary Of The Army | Electrochemical test apparatus and method for its use |
US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
US20160154928A1 (en) * | 2013-07-12 | 2016-06-02 | Immuneering Corporation | Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or condition |
MX2019008078A (es) | 2017-02-14 | 2019-11-05 | Res Triangle Inst | Moduladores de receptores neuropeptido basados en prolina. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4698342A (en) * | 1985-07-16 | 1987-10-06 | Serotonin Industries Of Charleston | Method and compositions for controlling pain, depression and sedation |
US5420151A (en) * | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
US5616610A (en) * | 1989-12-22 | 1997-04-01 | Astra Aktiebolag | (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans |
SE9501567D0 (sv) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
-
1995
- 1995-04-27 SE SE9501567A patent/SE9501567D0/xx unknown
-
1996
- 1996-04-15 TW TW085104481A patent/TW458777B/zh not_active IP Right Cessation
- 1996-04-15 ZA ZA962982A patent/ZA962982B/xx unknown
- 1996-04-21 IL IL11798896A patent/IL117988A0/xx not_active IP Right Cessation
- 1996-04-23 EP EP96912370A patent/EP0822813B1/en not_active Expired - Lifetime
- 1996-04-23 WO PCT/SE1996/000526 patent/WO1996033710A1/en active IP Right Grant
- 1996-04-23 ES ES96912370T patent/ES2175089T3/es not_active Expired - Lifetime
- 1996-04-23 HU HU9801946A patent/HUP9801946A3/hu unknown
- 1996-04-23 RU RU97119427/14A patent/RU2183955C2/ru active
- 1996-04-23 CA CA002218181A patent/CA2218181A1/en not_active Abandoned
- 1996-04-23 DK DK96912370T patent/DK0822813T3/da active
- 1996-04-23 NZ NZ306602A patent/NZ306602A/en unknown
- 1996-04-23 SK SK1429-97A patent/SK282060B6/sk unknown
- 1996-04-23 CN CN96194810A patent/CN1102386C/zh not_active Expired - Fee Related
- 1996-04-23 BR BR9608252A patent/BR9608252A/pt not_active Application Discontinuation
- 1996-04-23 US US08/640,896 patent/US5962514A/en not_active Expired - Fee Related
- 1996-04-23 KR KR1019970707592A patent/KR100419810B1/ko not_active IP Right Cessation
- 1996-04-23 PT PT96912370T patent/PT822813E/pt unknown
- 1996-04-23 PL PL96323083A patent/PL183997B1/pl unknown
- 1996-04-23 TR TR97/01254T patent/TR199701254T1/xx unknown
- 1996-04-23 JP JP8532425A patent/JPH11504037A/ja not_active Ceased
- 1996-04-23 CZ CZ973356A patent/CZ335697A3/cs unknown
- 1996-04-23 AT AT96912370T patent/ATE216579T1/de not_active IP Right Cessation
- 1996-04-23 EE EE9700245A patent/EE03553B1/xx not_active IP Right Cessation
- 1996-04-23 DE DE69620878T patent/DE69620878T2/de not_active Expired - Fee Related
- 1996-04-25 AR ARP960102323A patent/AR002990A1/es not_active Application Discontinuation
- 1996-04-26 YU YU25696A patent/YU25696A/sh unknown
-
1997
- 1997-10-09 IS IS4585A patent/IS1821B/is unknown
- 1997-10-24 NO NO19974921A patent/NO317057B1/no unknown
-
1998
- 1998-03-10 HK HK98101990A patent/HK1002853A1/xx not_active IP Right Cessation
-
1999
- 1999-07-09 US US09/351,071 patent/US6184219B1/en not_active Expired - Fee Related
- 1999-07-09 US US09/351,069 patent/US6169098B1/en not_active Expired - Fee Related
- 1999-07-09 US US09/351,070 patent/US6172105B1/en not_active Expired - Fee Related
- 1999-07-09 US US09/349,590 patent/US6184218B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR002990A1 (es) | Una nueva combinacion de un inhibidor de reabsorcion de 5-ht y un antagonista 5-ht(1a), su uso para la preparacion de medicamentos, una formulacion farmaceutica que la comprende, un procedimiento para la preparacion de dicha combinacion y equipo que contiene dicha combinacion. | |
UY27740A1 (es) | Nuevos compuestos | |
UY28150A1 (es) | Agentes terapeuticos | |
UY28215A1 (es) | Quinazolinas utiles como moduladores de canales iónicos | |
NO20060402L (no) | 3-amino choman og 2-aminotetralinderivater | |
UY26020A1 (es) | Inhibidores de la recaptacion de monoaminas para el tratamiento de trastornos del snc. | |
ECSP055738A (es) | PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL | |
GT199800046A (es) | Compuestos de pirazina. | |
BRPI0212733B8 (pt) | composição farmacêutica compreendendo composto inibidor da recaptação de serotonina, e, uso do mesmo | |
PA8593101A1 (es) | Composiciones para el tratamiento de crecimiento celular anormal | |
CL2007002450A1 (es) | Forma polimorfica i del enantiomero levogiro o dextrogiro de modafinilo; su procedimiento de preparacion; y composicion farmaceutica que los comprende (divisional solicitud 2693-03). | |
HN1998000157A (es) | Agonistas de prostaglandinas | |
UY27872A1 (es) | Inhibidores de caspasa y usos de los mismos. | |
DK1697371T3 (da) | Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer | |
PA8580301A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
CL2008001465A1 (es) | Compuestos derivados de [2,1,3]benzoxadiazol-5-carboxamidas, moduladores de los receptores ampa; composiciones farmacéuticas; y su uso en el tratamiento de afecciones hipoglutamatérgicas, trastornos cognitivos, enfermedad de parkinson, adhd, síndrome de rett, depresión respiratoria, síndrome x frágil y enfermedad de alzheimer. | |
DK1506185T3 (da) | Forbindelser og deres anvendelse som 5-HT-inhibitorer | |
ECSP056192A (es) | 3-fluoro-piperidinas como antagonistas de nmda/nr2b | |
PA8525001A1 (es) | Compuestos de 1,4-dihidropiridina como antagonistas de bradicinina | |
UY26924A1 (es) | Derivados de fenoxibencilamina como ssri | |
CR10062A (es) | Composiciones y metodos de tratamiento para trastornos del sistema nervioso central | |
SV2004001555A (es) | Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos | |
BR0308133A (pt) | Forma polimórfica cristalina de cloridrato de irinotecan | |
AR013503A1 (es) | Una combinacion de un inhibidor de la monoamina oxidasa y un antagonista o agonista parcial selectivo de h5-ht(1b), formulacion farmaceutica, usos ymetodo de preparacion | |
CO5611124A2 (es) | Derivados de benzofurano substituidos utiles en el tratamiento de desordenes hiper-proliferativos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |